nature-medicine
Nature Medicine (nature-medicine)
Journal positioning
Nature Medicine, published by Springer Nature, is the premier translational and clinical medicine journal in the Nature family. It publishes research that moves from biological mechanism to clinical application—spanning fundamental disease biology, biomarker discovery, clinical trials, and computational medicine—as long as the work has direct and demonstrated relevance to human disease. The journal demands both biological depth and clinical plausibility; purely preclinical studies without a clear translational bridge, and purely clinical studies without mechanistic insight, each face a steep hurdle. The readership spans translational researchers, physician-scientists, and clinical trialists worldwide.
This skill is a fit / venue-selection / re-framing tool. It does not replace the journal's current official submission guidelines. Before submitting, re-check the live author instructions on the Springer Nature site or submission system.
When to trigger
- The author names Nature Medicine as the target venue for a translational study, first-in-human trial, or biomarker/diagnostic discovery.
- A manuscript moves from a mechanistic finding in human tissue or model systems to a clinical cohort or trial and needs guidance on framing the translational arc.
- A clinical genomics, AI/ML-based diagnostic, or multi-omics disease-subtyping study needs a venue that bridges discovery science and clinical impact.
- The author needs Nature Medicine's desk-reject risks and credible alternatives before submitting.